News

Net profit of Sanofi India rose 20.14% to Rs 83.50 crore in the quarter ended June 2026 as against Rs 69.50 crore during the previous quarter ended June 2025. Sales rose 7.73% to Rs 437.70 crore in the quarter ended June 2026 as against Rs 406.30 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales437.70406.30 8 OPM %26.3423.36 - PBDT121.20103.20 17 PBT112.3094.10 19 NP83.5069.50 20 Powered by Capital Market - Live News

Sanofi India will hold a meeting of the Board of Directors of the Company on 4 August 2026.

Sanofi India announced the appointment of Debajit Roy as Sales & Customer Engagement Head - Diabetes, designated as Senior Management Personnel of the Company with effect from 8 June 2026.

Net profit of Sanofi India declined 14.14% to Rs 102.60 crore in the quarter ended March 2026 as against Rs 119.50 crore during the previous quarter ended March 2025. Sales declined 11.87% to Rs 472.30 crore in the quarter ended March 2026 as against Rs 535.90 crore during the previous quarter ended March 2025. ParticularsQuarter EndedMar. 2026Mar. 2025% Var. Sales472.30535.90 -12 OPM %30.2432.08 - PBDT146.90174.90 -16 PBT137.90165.30 -17 NP102.60119.50 -14 Powered by Capital Market - Live News

Sanofi India will hold a meeting of the Board of Directors of the Company on 28 April 2026.